SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-002319
Filing Date
2023-01-24
Accepted
2023-01-24 16:15:37
Documents
14
Period of Report
2023-01-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 36770
2 ex99-1.htm EX-99.1 13294
3 ex99-1_001.jpg GRAPHIC 4389
  Complete submission text file 0001493152-23-002319.txt   235735

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ghsi-20230124.xsd EX-101.SCH 3245
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ghsi-20230124_lab.xml EX-101.LAB 34240
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ghsi-20230124_pre.xml EX-101.PRE 22371
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3728
Mailing Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098
Business Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098 (800) 873-5141
Guardion Health Sciences, Inc. (Filer) CIK: 0001642375 (see all company filings)

IRS No.: 474428421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38861 | Film No.: 23548303
SIC: 2834 Pharmaceutical Preparations